EQUITY RESEARCH MEMO
IRadimed (IRMD)
Generated 5/9/2026
Executive Summary
Conviction (model self-assessment)70/100
IRadimed Corporation is a specialized medical device company that develops non-magnetic equipment for patient care within MRI environments. Its proprietary portfolio includes the world’s only non-magnetic MRI patient monitors and the MRidium line of MRI-safe IV infusion pump systems, along with ferrous metal detection systems. These products address critical safety and continuity-of-care challenges for high-acuity patients undergoing MRI procedures. With a focused product line and a strong intellectual property position, IRadimed has established itself as the leading provider of MRI-compatible monitoring and infusion solutions, primarily targeting hospital radiology departments and critical care units.
Upcoming Catalysts (preview)
- Q3 2026FDA 510(k) clearance for next-generation MRI-safe infusion pump80% success
- Q4 2026Expansion into European market via CE mark approval for infusion pump70% success
- Q2 2026Q2 2026 earnings release with potential guidance upgrade90% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)